4.7 Article

Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records

Journal

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Volume 51, Issue 6, Pages 1813-1823

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ije/dyac140

Keywords

Cardiovascular disease; risk prediction; type 2 diabetes; variability; repeated measurements; electronic health records

Funding

  1. UK Medical Research Council [MR/L003120/1]
  2. British Heart Foundation (BHF) [RG/13/13/30194, RG/18/13/33946]
  3. BHF Cambridge Centre for Research Excellence [RE/13/6/30180]
  4. National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre [BRC-1215-20014]
  5. Health Data Research UK - UK Medical Research Council
  6. Public Health Agency (Northern Ireland)
  7. British Heart Foundation
  8. Wellcome
  9. Chinese Scholarship Council
  10. British Heart Foundation Programme Grant [RG/18/13/33946]
  11. Medical Research Council (MRC)
  12. School of Clinical Medicine at University of Cambridge
  13. National Institute for Health Research Cambridge Biomedical Research Centre (BRC) [BRC-1215-20014]
  14. BHF PhD studentship [FS/18/56/34177]
  15. Cancer Research UK [C18081/A31373]
  16. Canary Center at Stanford University
  17. University of Cambridge
  18. University College London
  19. University of Manchester
  20. MRC [MC_UU_00002/5]
  21. British Heart Foundation Chair award [CH/12/2/29428]
  22. Innovative Medicines Initiative-2 Joint Undertaking [116074]
  23. BHF-Turing Cardiovascular Data Science Award [BCDSA\100005]
  24. Engineering and Physical Sciences Research Council
  25. Economic and Social Research Council
  26. Department of Health and Social Care (England)
  27. Chief Scientist Office of the Scottish Government Health and Social Care Directorates
  28. Health and Social Care Research and Development Division (Welsh Government)
  29. British Heart Foundation-Turing Cardiovascular Data Science Award
  30. Oregon Health & Science University (OHSU) Knight Cancer Institute
  31. Medical Research Council [MC_UU_00002/5] Funding Source: researchfish

Ask authors/readers for more resources

Incorporating variability of risk factors from electronic health records improves cardiovascular disease (CVD) risk discrimination for individuals with type 2 diabetes.
Background Cardiovascular disease (CVD) risk prediction models for individuals with type 2 diabetes are important tools to guide intensification of interventions for CVD prevention. We aimed to assess the added value of incorporating risk factors variability in CVD risk prediction for people with type 2 diabetes. Methods We used electronic health records (EHRs) data from 83 910 adults with type 2 diabetes but without pre-existing CVD from the UK Clinical Practice Research Datalink for 2004-2017. Using a landmark-modelling approach, we developed and validated sex-specific Cox models, incorporating conventional predictors and trajectories plus variability of systolic blood pressure (SBP), total and high-density lipoprotein (HDL) cholesterol, and glycated haemoglobin (HbA(1c)). Such models were compared against simpler models using single last observed values or means. Results The standard deviations (SDs) of SBP, HDL cholesterol and HbA(1c) were associated with higher CVD risk (P < 0.05). Models incorporating trajectories and variability of continuous predictors demonstrated improvement in risk discrimination (C-index = 0.659, 95% CI: 0.654-0.663) as compared with using last observed values (C-index = 0.651, 95% CI: 0.646-0.656) or means (C-index = 0.650, 95% CI: 0.645-0.655). Inclusion of SDs of SBP yielded the greatest improvement in discrimination (C-index increase = 0.005, 95% CI: 0.004-0.007) in comparison to incorporating SDs of total cholesterol (C-index increase = 0.002, 95% CI: 0.000-0.003), HbA(1c) (C-index increase = 0.002, 95% CI: 0.000-0.003) or HDL cholesterol (C-index increase= 0.003, 95% CI: 0.002-0.005). Conclusion Incorporating variability of predictors from EHRs provides a modest improvement in CVD risk discrimination for individuals with type 2 diabetes. Given that repeat measures are readily available in EHRs especially for regularly monitored patients with diabetes, this improvement could easily be achieved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available